0
Upcoming Allied Market Research
2022
Regenerative Medicine For Cartilage Market

Regenerative Medicine for Cartilage Market

By Treatment Modality (Cell-based and Non-cell-based), Treatment Type (Palliative, Intrinsic Repair Stimulus, and Others), Site (Knee Cartilage Repair, Ribs, and Others), and Application (Hyaline, Elastic, and Fibrous Cartilage), End User (Hospitals, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

Report Code: A13589
Pages: NA
Nov 2022 | 752 Views
Author(s) : Onkar S
Tables: 9
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Regenerative Medicine For Cartilage Market

Request Now !

Regenerative medicine replacing, engineering, or regenerating human or animal cells, tissues, or organs to restore or establish normal function. The regenerative medicine for cartilage consists of sales of entities (organizations, sole traders, and partnerships) that can grow muscles and organs in the lab and safely implant them when the body is unable to regenerate itself after injury or wear.

The major types of cartilage regenerative medicines are cell-based and non-cell-based. The type of treatment includes palliative and intrinsic repair stimulus. The regenerative medicine for cartilage is used for the repair and regeneration of hyaline cartilage, elastic cartilage, and fibrous cartilage. Modern cartilage regeneration methods include autologous chondrocyte implantation (ACI), autologous matrix-induced chondrogenesis (AMIC), and matrix-associated autologous chondrocyte implantation (MACI).

Market Scope and Structure Analysis

Report Metric

Details

Market Size Available for Years

2020–2030

Base Year Considered

2020

Forecast Period

2021–2030

Forecast Unit

Value (USD)

Segments Covered

Product Type, Application, End User, and Region

Regions Covered

North America, Europe, Asia-Pacific, LAMEA

Companies Covered

B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix, Osiris Therapeutics Inc., and DePuy Synthes

 

COVID-19 Impact analysis

The COVID-19 impacted the global regenerative medicine for cartilage market in the initial phase pandemic. Elective surgeries are being canceled or postponed to reserve the available limited capacities and resources such as hospital beds and healthcare professionals toward COVID-19 patient care. Moreover, to control the rising number of positive COVID-19 cases, several countries have implemented lockdowns and curfews. Furthermore, patients are unable to visit hospitals, clinics, or OPDs due to the lockdowns. The cartilage repair and regeneration industries are projected to be hindered by the temporary denial of wound care services, cancer care surgeries/therapies, and other healthcare services.

Top Impacting Factors

  • Increasing geriatric population generating incidences of articular damage in knees will propel the regenerative medicine for cartilage market.
  • Emerging clinical trials and the development of new technologies (stem cells, gene therapy, tissue engineering, and cartilage restoration technologies) that transform the cartilage regeneration market are thriving the market growth.
  • Additionally, factors such as the rising government investments in cartilage regeneration research, increasing number of companies making significant investments in R&D, resulting in a strong pipeline of products based on various approaches to cartilage repair are boosting the market growth.
  • Moreover, growth factors in the form of platelet-rich plasma (PRP) therapy are injected to promote tissue regeneration effectively is also propelling the market.
  • However, high cost of regenerative medicine therapies for the cartilage market hinders the growth of the market.

Market Trends

New product launches to flourish the market

In April 2019, Smith & Nephew Plc., a UK-based multinational medical equipment manufacturing company, acquired Osiris Therapeutics, Inc. for approximately $660 million. The acquisition is expected to stimulate growth from Smith & Nephew's advanced wound management franchise. Osiris Therapeutics, Inc. is a US-based company that researches and develops therapeutic products for the regeneration of human connective tissues.

In 2019, MEDIPOST (South Korea) expanded the GMP manufacturing facility to accelerate CARTISTEM production.

In 2018, Vericel Corporation collaborated with Innovative Cellular Therapeutics (ICT, China), under this collaboration, ICT will develop and distribute MACI, Epicel, Ixmyelocel-T, and Carticel products in China, South Korea, Singapore, and other countries in Asia.

Surge in incidence of osteoarthritis

The growing incidence of osteoarthritis across the globe will surge the market growth for regenerative medicine for cartilage. Osteoarthritis is a degenerative joint disorder that generally attacks the articular cartilage.

According to the Arthritis Foundation (2019), degenerative joint illnesses such as osteoarthritis will affect at least 130 million people worldwide by 2050. Autologous chondrocyte implantation and scaffold implants are two of the most common treatments for osteoarthritis. Thus, the increasing incidence of osteoarthritis is expected to drive the demand for regenerative medicine for the cartilage market.

Key Segments Covered

Segment

Subsegment

By Treatment Modality

  • Cell-based
    • Chondrocyte Transplantation
    • Stem Cells
    • Growth Factors
  • Non-cell-based
    • Tissue Scaffolds
    • Cell-free Composites

By Treatment Type

  • Palliative
  • Intrinsic Repair Stimulus
  • Others

By Site

  • Knee Cartilage Repair
  • Ribs
  • Others

Application

  • Hyaline Cartilage
  • Elastic Cartilage
  • Fibrous Cartilage

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


Key Benefits of the Report

  • This study presents the analytical depiction of the regenerative medicine for cartilage along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the regenerative medicine for cartilage market share.
  • The current market is quantitatively analyzed from 2020 to 2030 to highlight the regenerative medicine for cartilage market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed regenerative medicine for cartilage market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Regenerative Medicine for Cartilage Report

  • Who are the leading market players active in the regenerative medicine for cartilage market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What future projections would help in taking further strategic steps?
  • What is "regenerative medicine for cartilage "?
  • What is "regenerative medicine for cartilage " market prediction in the future?
  • Who are the leading global players in the "regenerative medicine for cartilage " market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "regenerative medicine for cartilage " market report?

Regenerative Medicine for Cartilage Market Report Highlights

Aspects Details
By Treatment Modality
  • Cell based
    • Chondrocyte Transplantation
    • Stem Cells
    • Growth Factors
  • Non cell based
    • Tissue Scaffolds
    • Cell free Composites
By Treatment Type
  • Palliative
  • Intrinsic Repair Stimulus
  • Others
By Site
  • Knee Cartilage Repair
  • Ribs
  • Others
By Application
  • Hyaline Cartilage
  • Elastic Cartilage
  • Fibrous Cartilage
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith and Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Regenerative Medicine For Cartilage Market

Start reading.
This Report and over 19,300+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers